Adjusted* prevalence risk ratios (PRs) of detectable plasma HIV RNA and mean differences in plasma HIV RNA and CD4+ T cell counts (from the GEE analysis with robust variance estimation) by degree of HSV-2 clinical activity.

<p>Note: GEE, Generalized Estimating Equations; CI, confidence interval; PR, prevalence ratio; <i>P</i>, p-value; SR GH, self reported genital herpes; L-V, lesion-visit; ^*adjusted for baseline CD4+ T cell count, herpes medications and type of antiretroviral therapy used at the visit, age, race, lifetime number of sexual partners, injection and noninjection drug use; ^†positive self report of genital herpes only; ^‡number of visits with lesions.